SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-009957
Filing Date
2021-09-13
Accepted
2021-09-13 06:05:35
Documents
18
Period of Report
2021-09-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT vtgn_8k.htm   iXBRL 8-K 19726
2 PRESS RELEASE vtgn_ex991.htm EX-99.1 15795
3 IMAGE vtgn_ex991img1.jpg GRAPHIC 4696
4 IMAGE vtgn_ex991img2.jpg GRAPHIC 4696
5 IMAGE vtgn_ex991img3.jpg GRAPHIC 4696
  Complete submission text file 0001654954-21-009957.txt   181364

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vtgn-20210913.xsd EX-101.SCH 5595
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtgn-20210913_cal.xml EX-101.CAL 890
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtgn-20210913_def.xml EX-101.DEF 2097
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtgn-20210913_lab.xml EX-101.LAB 14244
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtgn-20210913_pre.xml EX-101.PRE 9037
11 EXTRACTED XBRL INSTANCE DOCUMENT vtgn_8k_htm.xml XML 3505
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37761 | Film No.: 211248519
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences